Thanh bên bài viết

PDF
Ngày xuất bản: 28/04/2025
Số lượt xem tóm tắt: 111
Số lượt xem PDF: 91
DOI: https://doi.org/10.56535/jmpm.v50i4.896
Số xuất bản
Tập 50 Số 4 (2025): TẠP CHÍ Y DƯỢC HỌC QUÂN SỰ SỐ 4 - 2025
Chuyên mục
Bài báo
Trích dẫn bài báo
Dao, N. B., Ta, B. T., & Nguyen, T. D. (2025). A RARE CASE REPORT: LUNG ADENOCARCINOMA WITH DIFFUSE LESIONS IN A YOUNG MALE PATIENT. Tạp chí Y Dược học Quân sự, 50(4), 51-58. https://doi.org/10.56535/jmpm.v50i4.896

A RARE CASE REPORT: LUNG ADENOCARCINOMA WITH DIFFUSE LESIONS IN A YOUNG MALE PATIENT

Dao Ngoc Bang1, , Ta Ba Thang1, Nguyen Tien Dung1
1 Respiratory Medicine Center, Military Hospital 103, Vietnam Military Medical University

Nội dung chính của bài viết

Tóm tắt

The images of diffuse lung involvement are seen in various respiratory diseases, including lung adenocarcinoma (ADC). After ruling out acute infectious causes, lung biopsy is valuable for a definitive diagnosis, with transbronchial biopsy via flexible bronchoscopy being an effective and safe diagnostic approach. However, the widespread lung damage in these patients poses a challenge for transbronchial biopsy. Chemotherapy is often difficult due to the overall poor health of the patient. Targeted therapies, specifically tyrosine kinase inhibitors (TKIs), have shown efficacy in lung cancer treatment.

Chi tiết bài viết

Từ khóa

Adenocarcinoma, Lung cancer, Tyrosine kinase inhibitors (TKIs)

Tài liệu tham khảo

1. WHO. Lung cancer. https://www. who.int/news-room/fact-sheets/detail/ lung-cancer. 2023.
2. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians. 2021; 71(3):209-249.
3. Rebanta K. Chakraborty; Sandeep Sharma. Bronchoalveolar Cancer. Treasure Island (FL): StatPearls Publishing; 2023 Jan.
4. Jon O. Ebbert, Laveena Chhatwani, Marie Christine Aubry, et al. Clinical features of bronchioloalveolar carcinoma with new histologic and staging definitions. Journal of Thoracic Oncology. August 2010; 5(8):1213-1220.
5. Boitsios G, Bankier AA, Eisenberg RL. Diffuse pulmonary nodules. AJR Am J Roentgenol. 2010; 194(5):W354-W366. DOI: 10.2214/AJR.10.4345.
6. David M. DiBardino, Anil Vachani, and Lonny Yarmus. Evaluating the efficacy of bronchoscopy for the diagnosis of early-stage lung cancer. J Thorac Dis. 2020 Jun; 12(6):3245-3252. DOI: 10.21037/jtd.2020.02.35.
7. Tianli Zhang, Bing Wan, Yuan Zhao, et al. Treatment of uncommon EGFR mutations in non-small cell lung cancer: New evidence and treatment. Transl Lung Cancer Res. 2019; 8(3):302-316. http://dx.doi.org/10.21037/tlc.
8. Shang-Gin Wu, Chong-Jen Yu, James Chih-Hsin Yang, et al. The effectiveness of afatinib in patients with lung adenocarcinoma harboring complex epidermal growth factor receptor mutation. Ther Adv Med Oncol. 2020; 12: 1758835920946156. DOI: 10.1177/ 1758835920946156.
9. Inger Johanne Zwicky Eide, Simone Stensgaard, Åslaug Helland, et al. Osimertinib in non-small cell lung cancer with uncommon EGFR-mutations: A post-hoc subgroup analysis with pooled data from two phase II clinical trials. Transl Lung Cancer Res. 2022 Jun; 11(6):953-963. DOI: 10.21037/tlcr-21-995.
10. Tomonari Kinoshita, Hideki Terai, Tomonori Yaguchi. Clinical efficacy and future prospects of immunotherapy in lung cancer. Life. 2021; 11(10):1029. https://doi.org/10.3390/life11101029.